Allogeneic Stem Cell Transplantation in Multiple Myeloma: Immunotherapy and New Drugs|
The authors examine the current evidence for the use of allogeneic stem cell transplantation in multiple myeloma. They review novel cell therapies that may be exploited to induce myeloma-specific immune responses including the new promising frontier of chimeric antigen receptor-T and -natural killer cells. [Expert Opin Biol Ther] Abstract
Visit our reviews page to see a complete list of reviews in the cord blood research field.